EyePoint Pharmaceuticals (NASDAQ: EYPT)
EyePoint Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
EyePoint Pharmaceuticals Company Info
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
News & Analysis
Why Shares of EyePoint Pharmaceuticals Were Rising Monday
The company reported positive trial data for its lead therapy to treat two different eye conditions.
Why EyePoint Pharmaceuticals Shot 31% Higher Today
The eyecare specialist has good momentum behind it as it prices a new round of capital raising.
Why EyePoint Pharmaceuticals Is Cratering Today
EyePoint's stock offering isn't sitting well with shareholders today. Here's why.
3 Top Small-Cap Stocks to Buy in October
These small-cap healthcare stocks are definitely worth checking out this month.
3 Top Biotech Stocks to Buy in September
These three biotech stocks could be great buys this month.
Here's Why EyePoint Pharmaceuticals Saw Its Share Price Drop Today
A secondary offering raised some cash but diluted current shareholders.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.